LEMAITRE VASCULAR INC LMAT revenue by segment, product and geography
In its fiscal year ending 2025-12-31, LEMAITRE VASCULAR INC reported revenue across 5 geographies; the largest, United States, was $142M, 56.7% of the filed sum (+10.0% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- United States$142M56.7%+10.0% yoy
- Other countries$61.7M24.7%+18.4% yoy
- Germany$17.9M7.2%+24.1% yoy
- Canada$15.3M6.1%+11.6% yoy
- United Kingdom$13.2M5.3%+20.6% yoy
Members sum to the consolidated $250M for this period.
- United States$37.2M55.9%+7.4% yoy
- Other countries$16.6M25.0%+15.6% yoy
- Germany$5.54M8.3%+39.3% yoy
- Canada$4.05M6.1%+8.9% yoy
- United Kingdom$3.13M4.7%-0.7% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.